Skip to main content
Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · IEX Real-Time Price · USD
0.709
-0.004 (-0.60%)
At close: Apr 25, 2024, 1:09 PM
0.704
-0.004 (-0.62%)
After-hours: Apr 25, 2024, 4:00 PM EDT

Lipella Pharmaceuticals Revenue

In the year 2023, Lipella Pharmaceuticals had annual revenue of $449.62K with 144.15% growth. Revenue in the quarter ending December 31, 2023 was $120.84K, a -19.98% decrease year-over-year.

Revenue (ttm)
$449.62K
Revenue Growth
+144.15%
P/S Ratio
9.85
Revenue / Employee
$89,923
Employees
5
Market Cap
4.43M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023449.62K265.46K144.15%
Dec 31, 2022184.16K-75.19K-28.99%
Dec 31, 2021259.35K-702.34K-73.03%
Dec 31, 2020961.68K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LIPO News

More News